Lansoprazol Sandoz

Lansoprazole, the active ingredient in Lansoprazol Sandoz, is a proton pump inhibitor presented as an oral tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and erosive esophagitis in adults.

GNH USA supplies Lansoprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazol Sandoz, a proton pump inhibitor, is used to manage conditions caused by excess gastric acid. - Gastro‑oesophageal reflux disease: reduces reflux symptoms and promotes healing of the esophageal lining. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence. - Helicobacter pylori eradication: used in combination therapy to eradicate H. pylori infection. - Erosive esophagitis: heals erosive lesions and prevents further damage.

Lansoprazol Sandoz may cause a range of adverse reactions. Most are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools, usually self‑limiting. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea, fever. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: jaundice, dark urine. - Acute interstitial nephritis: kidney inflammation, reduced urine output.

Before prescribing Lansoprazol Sandoz, consider the following safety measures. - Assess renal function: adjust use in severe kidney impairment. - Review hepatic status: monitor liver enzymes in patients with liver disease. - Evaluate long‑term use: consider bone health monitoring after prolonged therapy. - Check for drug interactions: avoid concomitant use with certain antivirals and antiplatelet agents. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lansoprazol Sandoz can affect the pharmacokinetics of several medicines. Review patient medication lists carefully.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased antiviral exposure, may lead to treatment failure. - Methotrexate (high dose): increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation parameters. - Digoxin: possible increase in serum levels, watch for toxicity signs. - Diazepam: enhanced sedation, adjust dose if necessary.